Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 17, 2017 - Issue 3
Submit an article Journal homepage
4,850
Views
41
CrossRef citations to date
0
Altmetric
Review

A systematic review of the health economic consequences of quadrivalent influenza vaccination

Pieter T. de BoerUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The NetherlandsCorrespondence[email protected]
View further author information
,
Britt M. van MaanenUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The NetherlandsView further author information
,
Oliver DammDepartment of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, GermanyView further author information
,
Bernhard UltschImmunisation Unit, Robert Koch Institute, Berlin, GermanyView further author information
,
Franklin C.K. DolkUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The NetherlandsView further author information
,
Pascal CrépeyDepartment of Quantitative Methods in Public Health, EHESP Rennes, Sorbonne Paris Cité, Rennes, France;UPRES-EA-7449 Reperes, University of Rennes 1, Rennes, FranceView further author information
,
Richard PitmanICON Health Economics and Epidemiology, Oxford, UKView further author information
,
Jan C. WilschutDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsView further author information
&
Maarten J. PostmaUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands;Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;Institute of Science in Healthy Aging & healthcaRE (SHARE), University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsORCID Iconhttp://orcid.org/0000-0002-6306-3653View further author information
ORCID Icon show all
Pages 249-265 | Received 03 Mar 2017, Accepted 13 Jun 2017, Published online: 28 Jun 2017

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Daniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Ruprecht Schmidt-Ott, Martin Eichner, Markus Schwehm, Gael Dos Santos, Bernhard Ultsch, Rafik Bekkat-Berkani, Alfred von Krempelhuber, Ilse Van Vlaenderen & Laure-Anne Van Bellinghen. (2022) Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany. Human Vaccines & Immunotherapeutics 18:5.
Read now
Pablo Manuel Bianculli, Lucile Bellier, Ignacio Olivera Mangado, Carlos Grau Pérez, Gustavo Mieres, Luis Lazarov, Audrey Petitjean, Hugo Dibarboure & Juan Guillermo Lopez. (2022) Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis. Human Vaccines & Immunotherapeutics 18:5.
Read now
Michele A. Kohli, Michael Maschio, Joaquin F. Mould-Quevedo, Michael Drummond & Milton C. Weinstein. (2021) The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom. Human Vaccines & Immunotherapeutics 17:11, pages 4603-4610.
Read now
Joyce Ojeda, José Luis Arredondo, Perla Salcedo, Mercedes Paredes-Paredes, Martin Dupuy, Celine Petit, Anne Laure Chabanon, Enrique Rivas, Sanjay Gurunathan, Iris De Bruijn & Stephanie Pepin. (2020) Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. Human Vaccines & Immunotherapeutics 16:6, pages 1380-1384.
Read now
Guillermo M. Ruiz-Palacios, John H. Beigel, Maria Lourdes Guerrero, Lucile Bellier, Ramiro Tamayo, Patricia Cervantes, Fabián P. Alvarez, Arturo Galindo-Fraga, Felipe Aguilar-Ituarte & Juan Guillermo Lopez. (2020) Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Human Vaccines & Immunotherapeutics 16:4, pages 827-835.
Read now
Ilaria Loperto, Andrea Simonetti, Antonio Nardone & Maria Triassi. (2019) Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence. Human Vaccines & Immunotherapeutics 15:5, pages 1035-1047.
Read now
Joon Young Song, Jacob Lee, Heung Jeong Woo, Seong-Heon Wie, Jin Soo Lee, Shin Woo Kim, Tae Hyong Kim, Sook-In Jung, Ji Yun Noh, Won Suk Choi, Hee Jin Cheong & Woo Joo Kim. (2019) Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults. Human Vaccines & Immunotherapeutics 15:3, pages 710-716.
Read now
Alberto Pérez Rubio & Jose María Eiros. (2018) Cell culture-derived flu vaccine: Present and future. Human Vaccines & Immunotherapeutics 14:8, pages 1874-1882.
Read now

Articles from other publishers (33)

Rodrigo Luiz Carregaro, Alessandra N. C. P. Roscani, Augusto Cesar Sousa Raimundo, Larissa Ferreira, Tazio Vanni, Maria da Graça Salomão, Livia Fernandes Probst & Juliana Yukari K. Viscondi. (2023) Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews. BMC Infectious Diseases 23:1.
Crossref
Clara R. Warmath, Ismael R. Ortega-Sanchez, Lindsey M. Duca, Rachael M. Porter, Molly G. Usher, Joseph S. Bresee, Kathryn E. Lafond & William W. Davis. (2023) Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review. Value in Health 26:5, pages 768-779.
Crossref
Rania Attia, Abdinasir Abubakar, Joseph Bresee, Osama Mere & Wasiq Khan. (2023) A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region. Influenza and Other Respiratory Viruses 17:3.
Crossref
Francisco Miguel Escandell Rico & Lucía Pérez Fernández. (2023) Efectividad de la vacuna antigripal en la prevención de la gripe en personas mayores de 65 años. Revista Española de Geriatría y Gerontología 58:1, pages 3-7.
Crossref
Jessica Tan, Veronika Chromikova, George O'Dell, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel, Florian Krammer & Meagan McMahon. (2022) Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model. mSphere 7:5.
Crossref
Analía Urueña, Paula Micone, María Cecilia Magneres, Ian McGovern, Joaquin Mould-Quevedo, Túlio Tadeu Rocha Sarmento & Norberto Giglio. (2022) Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina. Vaccines 10:10, pages 1627.
Crossref
Norbert Pardi, Juan Manuel Carreño, George O’Dell, Jessica Tan, Csaba Bajusz, Hiromi Muramatsu, Willemijn Rijnink, Shirin Strohmeier, Madhumathi Loganathan, Dominika Bielak, Molly M. H. Sung, Ying K. Tam, Florian Krammer & Meagan McMahon. (2022) Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses. Nature Communications 13:1.
Crossref
Jaline Cabral da Costa, Marilda Mendonça Siqueira, David Brown, Jonathan Oliveira Lopes, Braulia Caetano da Costa, Eric Lopes Gama & Maria de Lourdes Aguiar-Oliveira. (2022) Vaccine Mismatches, Viral Circulation, and Clinical Severity Patterns of Influenza B Victoria and Yamagata Infections in Brazil over the Decade 2010–2020: A Statistical and Phylogeny–Trait Analyses. Viruses 14:7, pages 1477.
Crossref
F.M. Escandell Rico, L. Pérez Fernández, L. Maciá Soler & J. Requena Puche. (2022) Efectividad de la vacuna antigripal en la prevención de la gripe grave. Journal of Healthcare Quality Research 37:4, pages 201-207.
Crossref
Gyeongseon Shin, Daewon Kang, Hee Jin Cheong & Sang-Eun Choi. (2022) Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population?. Vaccines 10:6, pages 932.
Crossref
Piyameth Dilokthornsakul, Le My Lan, Ammarin Thakkinstian, Raymond Hutubessy, Philipp Lambach & Nathorn Chaiyakunapruk. (2022) Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis. eClinicalMedicine 47, pages 101410.
Crossref
Dawei Zhu, Min Lv, Yunhua Bai, Jiang Wu & Ping He. (2022) Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis. Vaccine 40:7, pages 994-1000.
Crossref
Ismael R. Ortega-Sanchez, Joshua A. Mott, Wanitchaya Kittikraisak, Viengphone Khanthamaly, Margaret McCarron, Soukphadeth Keokhonenang, Phonepaseuth Ounaphom, Chansay Pathammavong, Kongxay Phounphenghack, Panome Sayamoungkhoun, Phetsavanh Chanthavilay, Joseph Bresee & Chankham Tengbriacheu. (2021) Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People’s Democratic Republic. Vaccine 39:52, pages 7633-7645.
Crossref
Van Hung Nguyen, Yvonne Hilsky & Joaquin Mould-Quevedo. (2021) The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach. Vaccines 9:10, pages 1095.
Crossref
Amine Amiche, Mine Durusu Tanriover, Lucile Bellier, Baris Ugur & Levent Akin. (2021) Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey. Value in Health Regional Issues 25, pages 15-22.
Crossref
Lucile Bellier, Audrey Petitjean, Tatiana Sarazu, Julio Tresierra & Juan Guillermo Lopez. (2021) Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme. Vaccine 39:30, pages 4144-4152.
Crossref
Analia Urueña, Paula Micone, Cecilia Magneres, Joaquin Mould-Quevedo & Norberto Giglio. (2021) Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina. Vaccines 9:4, pages 335.
Crossref
Tanja Fens, Pieter T. de Boer, Eugène P. van Puijenbroek & Maarten J. Postma. (2021) Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review. Vaccines 9:2, pages 111.
Crossref
Pascal Crépey, Louis Boiron, Rafael Rodrigo Araujo, Juan Guillermo Lopez, Audrey Petitjean & Expedito José de Albuquerque Luna. (2020) Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model. BMC Public Health 20:1.
Crossref
Ze Liu, Xingliang Geng, Zhaohai Cui, Weidong Li, Xia Ou & Guoyang Liao. (2020) Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature. Journal of Cellular and Molecular Medicine 24:19, pages 11198-11210.
Crossref
Pascal Crépey, Esther Redondo, Javier Díez-Domingo, Raúl Ortiz de Lejarazu, Federico Martinón-Torres, Ángel Gil de Miguel, Juan Luis López-Belmonte, Fabián P. Alvarez, Hélène Bricout & Míriam Solozabal. (2020) From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. PLOS ONE 15:5, pages e0233526.
Crossref
Martina Havlickova, Sophie Druelles, Helena Jirincova, Radomira Limberkova, Alexander Nagy, Anvar Rasuli & Jan Kyncl. (2019) Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016. BMC Infectious Diseases 19:1.
Crossref
Saverio Caini, Gabriela Kusznierz, Verònica Vera Garate, Sonam Wangchuk, Binay Thapa, Francisco José de Paula Júnior, Walquiria Aparecida Ferreira de Almeida, Richard Njouom, Rodrigo A. Fasce, Patricia Bustos, Luzhao Feng, Zhibin Peng, Jenny Lara Araya, Alfredo Bruno, Doménica de Mora, Mónica Jeannette Barahona de Gámez, Richard Pebody, Maria Zambon, Rocio Higueros, Rudevelinda Rivera, Herman Kosasih, Maria Rita Castrucci, Antonino Bella, Hervé A. Kadjo, Coulibaly Daouda, Ainash Makusheva, Olga Bessonova, Sandra S. Chaves, Gideon O. Emukule, Jean-Michel Heraud, Norosoa H. Razanajatovo, Amal Barakat, Fatima El Falaki, Adam Meijer, Gé A. Donker, Q. Sue Huang, Tim Wood, Angel Balmaseda, Rakhee Palekar, Brechla Moreno Arévalo, Ana Paula Rodrigues, Raquel Guiomar, Vernon Jian Ming Lee, Li Wei Ang, Cheryl Cohen, Florette Treurnicht, Alla Mironenko, Olha Holubka, Joseph Bresee, Lynnette Brammer, Mai T. Q. Le, Phuong V. M. Hoang, Clotilde El Guerche-Séblain & John Paget. (2019) The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLOS ONE 14:9, pages e0222381.
Crossref
Richard Pebody, Abdelmajid Djennad, Joanna Ellis, Nick Andrews, Diogo F P Marques, Simon Cottrell, Arlene J Reynolds, Rory Gunson, Monica Galiano, Katja Hoschler, Angie Lackenby, Chris Robertson, Mark O’Doherty, Mary Sinnathamby, Nikolaos Panagiotopoulos, Ivelina Yonova, Rebecca Webb, Catherine Moore, Matthew Donati, Muhammad Sartaj, Samantha J Shepherd, Jim McMenamin, Simon de Lusignan & Maria Zambon. (2019) End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Eurosurveillance 24:31.
Crossref
Jae-Won Yun, Min Joo Choi, Gyeong-Seon Shin, Jae-Ok Lim, Ji Yun Noh, Yun-Kyung Kim, Joon Young Song, Woo Joo Kim, Sang-Eun Choi & Hee Jin Cheong. (2019) Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea. PLOS ONE 14:1, pages e0209643.
Crossref
Cornelia Betsch, Constanze Rossmann, Mathias W. Pletz, Horst C. Vollmar, Antje Freytag, Ole Wichmann, Regina Hanke, Wolfgang Hanke, Dorothee Heinemeier, Philipp Schmid, Sarah Eitze, Winja Weber, Anne Reinhardt, Nora K. Küpke, Christina Forstner, Carolin Fleischmann-Struzek, Anna Mikolajetz, Josephine Römhild, Julia Neufeind, Thorsten Rieck, Kasia Suchecka & Konrad Reinhart. (2018) Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+. BMC Public Health 18:1.
Crossref
Yun-Kyung Kim, Joon Young Song, Hyeongap Jang, Tae Hyun Kim, Heejo Koo, Lijoy Varghese & Euna Han. (2018) Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. PharmacoEconomics 36:12, pages 1475-1490.
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Bruce Barrett, Mary S. Hayney, Daniel Muller, David Rakel, Roger Brown, Aleksandra E. Zgierska, Shari Barlow, Supriya Hayer, Jodi H. Barnet, Elisa R. Torres & Christopher L. Coe. (2018) Meditation or exercise for preventing acute respiratory infection (MEPARI-2): A randomized controlled trial. PLOS ONE 13:6, pages e0197778.
Crossref
Jan Hendriks, Raymond C.W. Hutubessy, Gary Grohmann, Guido Torelli, Martin Friede & Marie-Paule Kieny. (2018) Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability. Vaccine 36:28, pages 3993-3997.
Crossref
Pieter T. de Boer, Joel K. Kelso, Nilimesh Halder, Thi-Phuong-Lan Nguyen, Jocelyn Moyes, Cheryl Cohen, Ian G. Barr, Maarten J. Postma & George J. Milne. (2018) The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine 36:7, pages 997-1007.
Crossref
Bruna Lapinscki, Luciane A. Pereira, Meri B. Nogueira, Luine R. Vidal, Irina Riediger, Maria C. Debur, Mayra Presibella & Sonia M. Raboni. (2018) Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil. Vaccine 36:1, pages 107-113.
Crossref
Dominic Thorrington, Edwin van Leeuwen, Mary Ramsay, Richard Pebody & Marc Baguelin. (2017) Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Medicine 15:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.